Logo image of GL9.I

GLANBIA PLC (GL9.I) Stock Fundamental Analysis

DUB:GL9 - Euronext Dublin - IE0000669501 - Common Stock - Currency: EUR

12.7  -0.02 (-0.16%)

Fundamental Rating

5

Taking everything into account, GL9 scores 5 out of 10 in our fundamental rating. GL9 was compared to 59 industry peers in the Food Products industry. While GL9 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. GL9 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

GL9 had positive earnings in the past year.
GL9 had a positive operating cash flow in the past year.
Each year in the past 5 years GL9 has been profitable.
GL9 had a positive operating cash flow in each of the past 5 years.
GL9.I Yearly Net Income VS EBIT VS OCF VS FCFGL9.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

GL9 has a better Return On Assets (4.25%) than 61.02% of its industry peers.
With a Return On Equity value of 7.95%, GL9 perfoms like the industry average, outperforming 52.54% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 10.62%, GL9 belongs to the top of the industry, outperforming 88.14% of the companies in the same industry.
GL9 had an Average Return On Invested Capital over the past 3 years of 9.21%. This is above the industry average of 6.91%.
The 3 year average ROIC (9.21%) for GL9 is below the current ROIC(10.62%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.25%
ROE 7.95%
ROIC 10.62%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
GL9.I Yearly ROA, ROE, ROICGL9.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 4.29%, GL9 is in line with its industry, outperforming 55.93% of the companies in the same industry.
GL9's Profit Margin has declined in the last couple of years.
GL9's Operating Margin of 10.29% is fine compared to the rest of the industry. GL9 outperforms 64.41% of its industry peers.
GL9's Operating Margin has improved in the last couple of years.
GL9's Gross Margin of 30.35% is on the low side compared to the rest of the industry. GL9 is outperformed by 67.80% of its industry peers.
In the last couple of years the Gross Margin of GL9 has grown nicely.
Industry RankSector Rank
OM 10.29%
PM (TTM) 4.29%
GM 30.35%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
GL9.I Yearly Profit, Operating, Gross MarginsGL9.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GL9 is still creating some value.
GL9 has less shares outstanding than it did 1 year ago.
GL9 has less shares outstanding than it did 5 years ago.
GL9 has a worse debt/assets ratio than last year.
GL9.I Yearly Shares OutstandingGL9.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
GL9.I Yearly Total Debt VS Total AssetsGL9.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

GL9 has an Altman-Z score of 3.43. This indicates that GL9 is financially healthy and has little risk of bankruptcy at the moment.
GL9 has a Altman-Z score of 3.43. This is amongst the best in the industry. GL9 outperforms 83.05% of its industry peers.
The Debt to FCF ratio of GL9 is 2.69, which is a good value as it means it would take GL9, 2.69 years of fcf income to pay off all of its debts.
GL9 has a better Debt to FCF ratio (2.69) than 88.14% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that GL9 is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.45, GL9 is doing good in the industry, outperforming 62.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.69
Altman-Z 3.43
ROIC/WACC1.61
WACC6.58%
GL9.I Yearly LT Debt VS Equity VS FCFGL9.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

GL9 has a Current Ratio of 1.41. This is a normal value and indicates that GL9 is financially healthy and should not expect problems in meeting its short term obligations.
GL9 has a Current ratio (1.41) which is comparable to the rest of the industry.
GL9 has a Quick Ratio of 1.41. This is a bad value and indicates that GL9 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.81, GL9 perfoms like the industry average, outperforming 40.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.81
GL9.I Yearly Current Assets VS Current LiabilitesGL9.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for GL9 have decreased strongly by -51.61% in the last year.
GL9 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.73% yearly.
The Revenue for GL9 has decreased by -29.23% in the past year. This is quite bad
The Revenue has been decreasing by -0.19% on average over the past years.
EPS 1Y (TTM)-51.61%
EPS 3Y-0.29%
EPS 5Y9.73%
EPS Q2Q%-85.84%
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%-23.73%

3.2 Future

GL9 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.59% yearly.
The Revenue is expected to grow by 10.90% on average over the next years. This is quite good.
EPS Next Y-8.85%
EPS Next 2Y0.33%
EPS Next 3Y3.43%
EPS Next 5Y1.59%
Revenue Next Year1.16%
Revenue Next 2Y2.29%
Revenue Next 3Y2.79%
Revenue Next 5Y10.9%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GL9.I Yearly Revenue VS EstimatesGL9.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
GL9.I Yearly EPS VS EstimatesGL9.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.58, the valuation of GL9 can be described as reasonable.
76.27% of the companies in the same industry are more expensive than GL9, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of GL9 to the average of the S&P500 Index (27.30), we can say GL9 is valued rather cheaply.
A Price/Forward Earnings ratio of 11.65 indicates a reasonable valuation of GL9.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GL9 indicates a somewhat cheap valuation: GL9 is cheaper than 62.71% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. GL9 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.58
Fwd PE 11.65
GL9.I Price Earnings VS Forward Price EarningsGL9.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

66.10% of the companies in the same industry are more expensive than GL9, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, GL9 is valued a bit cheaper than 74.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.66
EV/EBITDA 7.33
GL9.I Per share dataGL9.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

GL9 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.09
EPS Next 2Y0.33%
EPS Next 3Y3.43%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.18%, GL9 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.27, GL9 has a dividend in line with its industry peers.
GL9's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

The dividend of GL9 is nicely growing with an annual growth rate of 33.32%!
Dividend Growth(5Y)33.32%
Div Incr Years6
Div Non Decr Years6
GL9.I Yearly Dividends per shareGL9.I Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

GL9 pays out 63.39% of its income as dividend. This is not a sustainable payout ratio.
GL9's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP63.39%
EPS Next 2Y0.33%
EPS Next 3Y3.43%
GL9.I Yearly Income VS Free CF VS DividendGL9.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
GL9.I Dividend Payout.GL9.I Dividend Payout, showing the Payout Ratio.GL9.I Dividend Payout.PayoutRetained Earnings

GLANBIA PLC

DUB:GL9 (7/11/2025, 7:00:00 PM)

12.7

-0.02 (-0.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)08-12 2025-08-12
Inst Owners22.32%
Inst Owner ChangeN/A
Ins Owners0.68%
Ins Owner ChangeN/A
Market Cap3.24B
Analysts80
Price Target16.48 (29.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend0.31
Dividend Growth(5Y)33.32%
DP63.39%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.78%
PT rev (3m)2.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 10.58
Fwd PE 11.65
P/S 0.99
P/FCF 10.66
P/OCF 8.57
P/B 1.83
P/tB 8.17
EV/EBITDA 7.33
EPS(TTM)1.2
EY9.45%
EPS(NY)1.09
Fwd EY8.58%
FCF(TTM)1.19
FCFY9.38%
OCF(TTM)1.48
OCFY11.67%
SpS12.84
BVpS6.93
TBVpS1.55
PEG (NY)N/A
PEG (5Y)1.09
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 7.95%
ROCE 14.01%
ROIC 10.62%
ROICexc 12.26%
ROICexgc 30.25%
OM 10.29%
PM (TTM) 4.29%
GM 30.35%
FCFM 9.27%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
ROICexc(3y)10.65%
ROICexc(5y)8.91%
ROICexgc(3y)25.6%
ROICexgc(5y)20.78%
ROCE(3y)11.85%
ROCE(5y)10%
ROICexcg growth 3Y28.93%
ROICexcg growth 5Y4.14%
ROICexc growth 3Y21.85%
ROICexc growth 5Y8.02%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.69
Debt/EBITDA 1.7
Cap/Depr 55.76%
Cap/Sales 2.27%
Interest Coverage 12.62
Cash Conversion 80.39%
Profit Quality 216.21%
Current Ratio 1.41
Quick Ratio 0.81
Altman-Z 3.43
F-Score6
WACC6.58%
ROIC/WACC1.61
Cap/Depr(3y)51.28%
Cap/Depr(5y)53.27%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.68%
Profit Quality(3y)136.16%
Profit Quality(5y)132.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-51.61%
EPS 3Y-0.29%
EPS 5Y9.73%
EPS Q2Q%-85.84%
EPS Next Y-8.85%
EPS Next 2Y0.33%
EPS Next 3Y3.43%
EPS Next 5Y1.59%
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%-23.73%
Revenue Next Year1.16%
Revenue Next 2Y2.29%
Revenue Next 3Y2.79%
Revenue Next 5Y10.9%
EBIT growth 1Y15.59%
EBIT growth 3Y19.97%
EBIT growth 5Y12.85%
EBIT Next Year23.49%
EBIT Next 3Y11.63%
EBIT Next 5Y8.58%
FCF growth 1Y0.56%
FCF growth 3Y21.96%
FCF growth 5Y21.96%
OCF growth 1Y3.48%
OCF growth 3Y16.3%
OCF growth 5Y16.3%